Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom P Freeman

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Journal of Psychopharmacology (Oxford, England)|March 1, 2021
Stimulating meditation: a pre-registered randomised controlled experiment combining a single dose of the cognitive enhancer, modafinil, with brief mindfulness trainingEmily M Thomas, Tom P Freeman, Patrick Poplutz, et al.
Nature Reviews. Neuroscience|April 8, 2016
Keep off the grass? Cannabis, cognition and addictionH Valerie Curran, Tom P Freeman, Claire Mokrysz, et al.
Addictive Behaviors|February 5, 2021
A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosityClare J Mackie, Jack Wilson, Tom P Freeman, et al.
Psychopharmacology|July 26, 2012
Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug useTom P Freeman, Celia J A Morgan, Fiona Pepper, et al.
The International Journal on Drug Policy|May 25, 2022
Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy StudyDavid Hammond, Samantha Goodman, Elle Wadsworth, et al.
Frontiers in Psychology|May 6, 2016
A Moderate Dose of Alcohol Does Not Influence Experience of Social Ostracism in Hazardous DrinkersJoseph Buckingham, Abigail Moss, Krisztina Gyure, et al.
Addiction (Abingdon, England)|April 2, 2026
Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysisMonika Halicka, Francesca Spiga, Tom P Freeman, et al.
Psychological Medicine|February 4, 2021
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative reviewRachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, et al.
The Lancet. Psychiatry|August 1, 2016
Bringing together pharmacological and psychological approaches to mental health researchAbigail Moss, H Valerie Curran, Michael A P Bloomfield, et al.
Journal of Psychopharmacology (Oxford, England)|October 3, 2018
Restrictions on drugs with medical value: Moving beyond stalemateTom P Freeman, Mitul A Mehta, Joanna C Neill, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Journal of Psychopharmacology (Oxford, England)|March 1, 2021
Stimulating meditation: a pre-registered randomised controlled experiment combining a single dose of the cognitive enhancer, modafinil, with brief mindfulness trainingEmily M Thomas, Tom P Freeman, Patrick Poplutz, et al.
Nature Reviews. Neuroscience|April 8, 2016
Keep off the grass? Cannabis, cognition and addictionH Valerie Curran, Tom P Freeman, Claire Mokrysz, et al.
Addictive Behaviors|February 5, 2021
A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosityClare J Mackie, Jack Wilson, Tom P Freeman, et al.
Psychopharmacology|July 26, 2012
Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug useTom P Freeman, Celia J A Morgan, Fiona Pepper, et al.
The International Journal on Drug Policy|May 25, 2022
Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy StudyDavid Hammond, Samantha Goodman, Elle Wadsworth, et al.
Frontiers in Psychology|May 6, 2016
A Moderate Dose of Alcohol Does Not Influence Experience of Social Ostracism in Hazardous DrinkersJoseph Buckingham, Abigail Moss, Krisztina Gyure, et al.
Addiction (Abingdon, England)|April 2, 2026
Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysisMonika Halicka, Francesca Spiga, Tom P Freeman, et al.
Psychological Medicine|February 4, 2021
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative reviewRachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, et al.
The Lancet. Psychiatry|August 1, 2016
Bringing together pharmacological and psychological approaches to mental health researchAbigail Moss, H Valerie Curran, Michael A P Bloomfield, et al.
Journal of Psychopharmacology (Oxford, England)|October 3, 2018
Restrictions on drugs with medical value: Moving beyond stalemateTom P Freeman, Mitul A Mehta, Joanna C Neill, et al.
Pageof 20